Keyword: Racing Medication and Testing Consortium

  • RMTC Board Names Interim Director

    At its April 23 meeting the Racing Medication and Testing Consortium board of directors approved an agreement with The Jockey Club to engage the full-time services of Jamie Haydon as RMTC interim executive director.

  • AGSC Postpones Race-Day Medication Ban

    The Thoroughbred Owners and Breeders Association's American Graded Stakes Committee announced Feb. 24 it has postponed implementing a ban on race-day medication in graded stakes races for 2-year-olds in 2012.

  • No Salix in Graded Stakes for 2YOs in 2012

    The American Graded Stakes Committee said Aug. 10 it will employ a pilot program that will ban race-day medications -- primarily the anti-bleeding drug Salix -- in graded 2-year-old stakes in 2012.

  • RMTC: Tighten Salix Rules, Ban Adjunct Drugs

    An industry consortium supports administration of Salix by regulatory veterinarians only and a ban on adjunct bleeder drugs, but will continue to study a pilot program proposal to ban the use of race-day Salix in 2-year-olds.

  • Officials Confirm International Drug Summit

    As expected the Racing Medication and Testing Consortium board of directors said April 20 it will join the National Thoroughbred Racing Association and American Association of Equine Practitioners in organizing a drug summit.

  • International Drug Summit Said to Be Planned

    Industry organizations including the National Thoroughbred Racing Association will propose an international summit on equine medication this year in the wake of calls for the race-day ban of anti-bleeding drugs.

  • Sources: Waterman Leaving Post at RMTC

    Dr. Scot Waterman, executive director of the Racing Medication and Testing Consortium for almost 10 years, is leaving the post at the end of April, according to multiple industry sources.

  • RCI: Phase Out Use of Drugs in Five Years

    In an announcement that could meet with disagreement with some horsemen's groups and perhaps others, the Association of Racing Commissioners International has called for a five-year phase-out of equine medication in racing.

  • KY Drug Council Targets Corticosteroids

    The Kentucky Drug Equine Research Council, citing a need to explore use of corticosteroids in racehorses, agreed Feb. 9 to take bids for research into one of the drugs in the research planning phase.

  • Officials Cite Progress Made in Drug Testing

    Laboratories that test samples for the presence of drugs in California, Delaware, Kentucky, New York, Pennsylvania, West Virginia, and other states have signed letters of intent to submit to accreditation.

  • RMTC Acts to Reduce Potential Impact of Bute

    The Racing Medication and Testing Consortium has lowered the testing threshold level for phenylbutazone, a commonly used non-steroidal anti-inflammatory drug, but has kept the administration time at 24 hours prior to a race.

  • Possible Change in Drug Rules Questioned

    The Association of Racing Commissioners International is looking at extending the cutoff time for use of non-steroidal anti-inflammatory drugs in racehorses beyond 24 hours prior to a race, but horsemen's groups claim the action is premature.

  • RMTC Board Approves New Testing Standards

    The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.

  • Horsemen, Chemist: Drug Problem Exaggerated

    The National Horsemen's Benevolent and Protective Association said July 1 it plans to be more involved as the racing industry considers medication and drug-testing policies horsemen believe could be detrimental and counterproductive.

  • International Drug Coalition Meets Recently

    The International Federation of Horse Racing Authorities Advisory Council on Prohibited Substances and representatives of the Racing Medication and Testing Consortium recently met in Lexington during the 75th convention of the Association of Racing Commissioners International and were sponsored by The Jockey Club.

  • Changes Ahead for Drug-Testing Protocol

    The Racing Medication and Testing Consortium is developing protocol designed to streamline and improve equine drug-testing in the United States. And it is taking a few pages from a 1991 study that didn't gain any traction in the racing industry when it was released.

  • New Targets for Medication Regulation

    Though most racing jurisdictions in North America have greatly curtailed the use of race-day medication, two drugs commonly used in racehorses are getting a hard look from industry officials.

  • Michigan ORC Bans Steroids

    Michigan horse racing commissioner Christine C. White April 1 gave notice to the state's horse racing industry that effective immediately, the presence of anabolic steroids will be prohibited in all horses entered to race at any pari-mutuel track in Michigan.

  • Advances in Equine Drug Testing Revealed

    The Thoroughbred Owners and Breeders Association, trainer Michael Matz, and owners Roy and Gretchen Jackson, have invited the public to attend a presentation by Dr. Lawrence R. Soma of the University of Pennsylvania School of Veterinary Medicine's New Bolton Center and Dr. Scot Waterman of the Racing Medication and Testing Consortium.

  • Frozen-Sample Drug Tests Get Funding

    The Jockey Club Thoroughbred Safety Committee said Feb. 11 it will fund a Racing Medication and Testing Consortium frozen-sample and retrospective testing program that will begin in April.

  • Thoroughbred Racing Associations CEO Alan Foreman speaks at The Jockey Club Round Table conference.

    Drug Testing Next Focus of Reform Plan

    The horseracing industry will continue with a serious push to enact reforms related to equine safety and drug testing, officials indicated Aug. 17 during and after The Jockey Club Round Table in Saratoga Springs, N.Y.

  • KY Officials Vow to Regulate Steroids

    Kentucky racing officials said they intend on having regulations for use of anabolic steroids in racehorses in place as quickly as possible, but discussion and research are still needed.

  • More Questions Than Answers on Steroids

    The complicated nature of regulating anabolic steroids in racehorses came to light May 20 when discussion among members of the Kentucky Equine Drug Research Council and others seemed to indicate the easiest route is an all-out ban on the substances.

  • Alex Waldrop believes the Thoroughbred industry responded appropriately in the wake of the breakdown of Eight Belles.

    Equine Welfare Key No Matter the Outcome

    The National Thoroughbred Racing Association is prepared for "every potential outcome" on Preakness Stakes (gr. I) day, but no matter the result, developments in the area of equine health and welfare in the coming weeks and months are of the utmost importance, the organization's president and chief executive officer said.

  • RMTC Strives for Uniform Drug Testing

    The Racing Medication and Testing Consortium sponsored an equine racing chemist workshop to foster uniformity in drug testing of the androgenic anabolic steroids from April 27-30 at the University of California at Davis.

  • Regulation of Steroids Turns a Corner

    The ongoing process of regulating anabolic steroids in racehorses may have turned a corner March 25 when the Racing Medication and Testing Consortium made changes to its model rule. State regulators, however, remain concerned about funding for increased testing.

  • RMTC Board Recommends Steroid Policy

    The board of directors of the Racing Medication and Testing Consortium (RMTC), in consultation with the RMTC Scientific Advisory Committee, approved policy recommendations for the use of steroids. The action took place at an RMTC board meeting March 25 Austin, Texas.

  • RMTC Moves Ahead With Work on Steroids

    The Racing Medication and Testing Consortium will hold its spring board of directors meeting March 25 in conjunction with the Association of Racing Commissioners International annual convention in Austin, Texas.